DW-013

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameDW-013
Drug Alias NameDW-013
ClassificationOther
Mechanisms of ActionTEK receptor tyrosine kinase antagonists
TargetsTEK receptor tyrosine kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAshvattha Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAshvattha Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A